MediCaps Ltd
MediCaps (BSE)

45.05

56.74
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-

Stock View

-
Share on
The average score for MediCaps Ltd stands at 10 against 7, three months back.

Medi-Caps Limited is an India-based pharmaceutical company, which manufactures hard gelatin capsules. The Company, through its subsidiaries, operates a pharmaceutical organization and real estate, which is engaged in the marketing, production and distribution of pharmaceutical products. The Company’s products include empty hard gelatin capsules, halal gelatin capsules, sodium lauryl sulfate (SLS), preservative-free and liquid-filled capsules. Its manufactures empty hard gelatin capsules in sizes 00, 0el, 0, 1el, 1, 2, 3 and 4 in approximately 1,000 shades. Liquid filled capsules are manufactured to stringent specifications. It also manufactures preservative-free capsules as per the customer's requirement. The Company offers several types of capsule printing options, which include axial print, spin print and python printing. It prints company or brand logo, brand or product name and dosage details.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
51.01
100 DMA ()
53.09
200 DMA ()
51.08
52 Weeks Range
38.25
91.15
Street View :-
Bearish
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity